Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock

Equities

688016

CNE100003MJ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
122.8 CNY -0.83% Intraday chart for Shanghai MicroPort Endovascular MedTech Co., Ltd. -5.96% -5.99%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.54B 214M Sales 2025 * 1.95B 269M Capitalization 15.14B 2.1B
Net income 2024 * 650M 89.97M Net income 2025 * 799M 111M EV / Sales 2024 * 8.06 x
Net cash position 2024 * 2.7B 374M Net cash position 2025 * 3.02B 418M EV / Sales 2025 * 6.23 x
P/E ratio 2024 *
23.3 x
P/E ratio 2025 *
18.8 x
Employees 908
Yield 2024 *
2.14%
Yield 2025 *
2.57%
Free-Float 57.59%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023 CI
EV MedTech Raises 1.8 Billion Yuan from Placement MT
MicroPort Endovascular MedTech Elects Chairman MT
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3 MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai MicroPort Endovascular MedTech's H1 Attributable Profit Increases 30% MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Bourse Approves EV MedTech's Proposed Share Issuance MT
EV MedTech Expects Up to 30% Increase in First-Half Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022 CI
More news
1 day-0.83%
1 week-5.96%
Current month-1.85%
1 month+8.63%
3 months+2.79%
6 months-11.17%
Current year-5.99%
More quotes
1 week
121.75
Extreme 121.75
131.51
1 month
111.88
Extreme 111.8792
133.93
Current year
98.66
Extreme 98.6644
133.93
1 year
98.66
Extreme 98.6644
141.14
3 years
89.29
Extreme 89.2886
322.15
5 years
67.79
Extreme 67.7852
322.15
10 years
67.79
Extreme 67.7852
322.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 18-06-30
Director of Finance/CFO 44 21-10-27
Director/Board Member 44 14-06-30
Members of the board TitleAgeSince
Chairman 56 18-07-30
Director/Board Member 47 18-07-30
Director/Board Member 56 18-07-30
More insiders
Date Price Change Volume
24-05-14 122.8 -0.83% 1,259,079
24-05-13 123.8 -2.28% 2,149,663
24-05-10 126.7 -2.11% 2,283,831
24-05-09 129.4 -0.31% 1,630,958
24-05-08 129.8 -0.56% 1,921,459

End-of-day quote Shanghai S.E., May 13, 2024

More quotes
Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
122.8 CNY
Average target price
156.8 CNY
Spread / Average Target
+27.72%
Consensus
  1. Stock Market
  2. Equities
  3. 688016 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW